Artificial intelligence-based pulmonary embolism classification: Development and validation using real-world data

被引:1
|
作者
da Silva, Luan Oliveira [1 ,3 ]
da Silva, Maria Carolina Bueno [1 ]
Ribeiro, Guilherme Alberto Sousa [1 ]
de Camargo, Thiago Fellipe Ortiz [1 ,2 ]
dos Santos, Paulo Victor [1 ,2 ]
Mendes, Giovanna de Souza [1 ]
de Paiva, Joselisa Peres Queiroz [1 ]
Soares, Anderson da Silva [3 ]
Reis, Marcio Rodrigues da Cunha [1 ,4 ]
Loureiro, Rafael Maffei [1 ]
Calixto, Wesley Pacheco [2 ,4 ]
机构
[1] Hosp Israelita Albert Einstein, Dept Radiol, Sao Paulo, Brazil
[2] Univ Fed Goias, Elect Mech & Comp Engn Sch, Goiania, Brazil
[3] Univ Fed Goias, Inst Informat INF, Goiania, Brazil
[4] Fed Inst Goias, Technol Res & Dev Ctr GCITE, Goiania, GO, Brazil
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
COMPUTED-TOMOGRAPHY PULMONARY; NEURAL-NETWORK; ANGIOGRAPHY; CTPA; OPTIMIZATION;
D O I
10.1371/journal.pone.0305839
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper presents an artificial intelligence-based classification model for the detection of pulmonary embolism in computed tomography angiography. The proposed model, developed from public data and validated on a large dataset from a tertiary hospital, uses a two-dimensional approach that integrates temporal series to classify each slice of the examination and make predictions at both slice and examination levels. The training process consists of two stages: first using a convolutional neural network InceptionResNet V2 and then a recurrent neural network long short-term memory model. This approach achieved an accuracy of 93% at the slice level and 77% at the examination level. External validation using a hospital dataset resulted in a precision of 86% for positive pulmonary embolism cases and 69% for negative pulmonary embolism cases. Notably, the model excels in excluding pulmonary embolism, achieving a precision of 73% and a recall of 82%, emphasizing its clinical value in reducing unnecessary interventions. In addition, the diverse demographic distribution in the validation dataset strengthens the model's generalizability. Overall, this model offers promising potential for accurate detection and exclusion of pulmonary embolism, potentially streamlining diagnosis and improving patient outcomes.
引用
下载
收藏
页数:22
相关论文
共 50 条
  • [1] Applications of artificial intelligence in drug development using real-world data
    Chen, Zhaoyi
    Liu, Xiong
    Hogan, William
    Shenkman, Elizabeth
    Bian, Jiang
    DRUG DISCOVERY TODAY, 2021, 26 (05) : 1256 - 1264
  • [2] Artificial intelligence-based classification of motor unit action potentials in real-world needle EMG recordings
    Hubers, Deborah
    Potters, Wouter
    Paalvast, Olivier
    de Jonge, Sterre
    Doelkahar, Brian
    Tannemaat, Martijn
    Wieske, Luuk
    Verhamme, Camiel
    CLINICAL NEUROPHYSIOLOGY, 2023, 156 : 220 - 227
  • [3] Exploring Physician Perspectives on Using Real-world Care Data for the Development of Artificial Intelligence-Based Technologies in Health Care: Qualitative Study
    Kamradt, Martina
    Poss-Doering, Regina
    Szecsenyi, Joachim
    JMIR FORMATIVE RESEARCH, 2022, 6 (05)
  • [4] Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application
    Huang, Kai
    Wu, Xian
    Li, Yixin
    Lv, Chengzhi
    Yan, Yangtian
    Wu, Zhe
    Zhang, Mi
    Huang, Weihong
    Jiang, Zixi
    Hu, Kun
    Li, Mingjia
    Su, Juan
    Zhu, Wu
    Li, Fangfang
    Chen, Mingliang
    Chen, Jing
    Li, Yongjian
    Zeng, Mei
    Zhu, Jianjian
    Cao, Duling
    Huang, Xing
    Huang, Lei
    Hu, Xing
    Chen, Zeyu
    Kang, Jian
    Yuan, Lei
    Huang, Chengji
    Guo, Rui
    Navarini, Alexander
    Kuang, Yehong
    Chen, Xiang
    Zhao, Shuang
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [5] Artificial intelligence-based model for dose prediction of sertraline in adolescents: a real-world study
    Fu, Ran
    Yu, Ze
    Zhou, Chunhua
    Zhang, Jinyuan
    Gao, Fei
    Wang, Donghan
    Hao, Xin
    Pang, Xiaolu
    Yu, Jing
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (02) : 177 - 187
  • [6] Disease Phenotype Discovery and Validation Can Optimally Inform Target Selection and Drug Development: Application of Artificial Intelligence-Based Analytics Using Real-World Evidence Big Data.
    Sarlis, Nicholas J.
    Liebman, Michael N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01)
  • [7] Real-world validation of Artificial Intelligence-based Computed Tomography auto-contouring for prostate cancer radiotherapy planning
    Palazzo, Gabriele
    Mangili, Paola
    Deantoni, Chiara
    Fodor, Andrei
    Broggi, Sara
    Castriconi, Roberta
    Gabellini, Maria Giulia Ubeira
    del Vecchio, Antonella
    Di Muzio, Nadia G.
    Fiorino, Claudio
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 28
  • [8] From real-world electronic health record data to real-world results using artificial intelligence
    Knevel, Rachel
    Liao, Katherine P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03) : 306 - 311
  • [9] Pattern Identification and Acupuncture Prescriptions Based on Real-World Data Using Artificial Intelligence
    Lee, Ye-Seul
    Chae, Younbyoung
    EAST ASIAN SCIENCE TECHNOLOGY AND SOCIETY-AN INTERNATIONAL JOURNAL, 2024,
  • [10] Toward safer ophthalmic artificial intelligence via distributed validation on real-world data
    Nath, Siddharth
    Rahimy, Ehsan
    Kras, Ashley
    Korot, Edward
    CURRENT OPINION IN OPHTHALMOLOGY, 2023, 34 (05) : 459 - 463